Updates matching "National"

The U.S. House of Representatives will soon consider legislation to increase access to health coverage for millions of Americans, including cancer patients and survivors, as part of its pandemic relief package.

Washington, D.C.—Today President Biden is expected to issue several executive orders aimed at expanding potential health coverage options for those who have lost health insurance due to the coronavirus pandemic, and rollback current policies that harm patient access to coverage.

Cancer patients would likely be among those most affected by a proposed rule tying certain Medicare Part B drug reimbursement rates to that of foreign countries.

The U.S. Senate passed legislation tonight aimed at improving access to clinical trials for communities of color and decreasing health disparities.

A new survey released today from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) finds overall tobacco use among middle and high school students has declined from 2019-2020. However, cigarette use did not decline.

More than a dozen patient groups representing millions of Americans with serious and chronic health conditions are urging the U.S. District Court for the Southern District of New York to preserve protections in the Affordable Care Act (ACA) for lesbian, gay, bisexual, transgender and queer (LGBTQ) patients receiving health care

Washington, D.C. —The Trump administration issued a interim final rule Friday that would significantly change how Medicare pays for certain prescription drugs. The “Most Favored Nation” policy would tie Medicare drug reimbursement for certain drugs to that of prices paid in select foreign countries. A statement from the American Cancer

As millions of seniors and other enrollees select their 2021 Medicare health benefits during annual open enrollment, a new report details just how confusing the program’s appeals process can be should a patient need to appeal a claim denial for health care services or prescription drugs.

According to an article published this week in JAMA Oncology , nearly 1 in 5 cancer patients surveyed said the pandemic would make them less likely to enroll in a trial. The top reason given for not enrolling is fear of COVID-19 exposure.